Polo-like kinase 1-mediated phosphorylation of forkhead box protein M1b antagonizes its SUMOylation and facilitates its mitotic function

Journal of Biological Chemistry

Volumn 290, Issue 6, 2015, Pages 3708-3719

  Zhang, Jinglei ^a   Yuan, Chengfu ^a   Wu, Jianguo ^a   Elsayed, Zeinab ^a   Fu, Zheng ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; ENZYMES; PROTEINS; SIGNALING;

IMMUNOFLUORESCENCE STAINING; NUCLEAR TRANSLOCATIONS; POST-TRANSLATIONAL MODIFICATIONS; PROTEASOMAL DEGRADATION; PROTEOLYTIC DEGRADATION; SUBCELLULAR FRACTIONATION; THERAPEUTIC INTERVENTION; TRANSCRIPTIONAL ACTIVITY;

PHOSPHORYLATION;

FORKHEAD BOX PROTEIN M1B; FORKHEAD TRANSCRIPTION FACTOR; POLO LIKE KINASE 1; PROTEASOME; SUMO 1 PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; FOXM1 PROTEIN, HUMAN; ONCOPROTEIN; POLO-LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CELL FRACTIONATION; CONJUGATION; CYTOSOL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MITOSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; REGULATORY MECHANISM; SUMOYLATION; ACTIVE TRANSPORT; CELL NUCLEUS; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; PHOSPHORYLATION;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL CYCLE PROTEINS; CELL NUCLEUS; FORKHEAD TRANSCRIPTION FACTORS; HEK293 CELLS; HELA CELLS; HUMANS; MITOSIS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS; SUMO-1 PROTEIN; SUMOYLATION;

EID: 84922351136     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.634386     Document Type: Article

References (41)

1. Clark, K. L., Halay, E. D., Lai, E., and Burley, S. K. (1993) Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364, 412-420
2. Laoukili, J., Stahl, M., and Medema, R. H. (2007) FoxM1: at the crossroads of ageing and cancer. Biochim. Biophys. Acta 1775, 92-102
3. Costa, R. H. (2005) FoxM1 dances with mitosis. Nat. Cell Biol. 7, 108-110
4. Wang, I. C., Chen, Y. J., Hughes, D., Petrovic, V., Major, M. L., Park, H. J., Tan, Y., Ackerson, T., and Costa, R. H. (2005) Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol. Cell. Biol. 25, 10875-10894
5. Wonsey, D. R., and Follettie, M. T. (2005) Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res. 65, 5181-5189
6. Pilarsky, C., Wenzig, M., Specht, T., Saeger, H. D., and Grützmann, R. (2004) Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 6, 744-750
7. Park, H. J., Wang, Z., Costa, R. H., Tyner, A., Lau, L. F., and Raychaudhuri, P. (2008) An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle. Oncogene 27, 1696-1704
8. Korver, W., Roose, J., and Clevers, H. (1997) The winged-helix transcription factor Trident is expressed in cycling cells. Nucleic Acids Res. 25, 1715-1719
9. Yao, K. M., Sha, M., Lu, Z., and Wong, G. G. (1997) Molecular analysis of a novel winged helix protein, WIN: expression pattern, DNA binding property, and alternative splicing within the DNA binding domain. J. Biol. Chem. 272, 19827-19836
10. Straight, A. F., Cheung, A., Limouze, J., Chen, I., Westwood, N. J., Sellers, J. R., and Mitchison, T. J. (2003) Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitor. Science 299, 1743-1747
11. Wierstra, I., and Alves, J. (2006) FOXM1c transactivates the human c-myc promoter directly via the two TATA boxes P1 and P2. FEBS J. 273, 4645-4667
12. Wierstra, I., and Alves, J. (2007) FOXM1c and Sp1 transactivate the P1 and P2 promoters of human c-myc synergistically. Biochem. Biophys. Res. Commun. 352, 61-68
13. Wierstra, I., and Alves, J. (2007) The central domain of transcription factor FOXM1c directly interacts with itself in vivo and switches from an essential to an inhibitory domain depending on the FOXM1c binding site. Biol. Chem. 388, 805-818
14. Wierstra, I., and Alves, J. (2007)FOXM1, a typical proliferation-associated transcription factor. Biol. Chem. 388, 1257-1274
15. Leung, T. W., Lin, S.S., Tsang, A. C, Tong, CS., Ching, J.C., Leung, W. Y., Gimlich, R., Wong, G. G., and Yao, K. M. (2001) Over-expression of FoxM1 stimulates cyclin B1 expression. FEBS Lett. 507, 59-66
16. Major, M. L., Lepe, R., and Costa, R. H. (2004) Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators. Mol. Cell. Biol. 24, 2649-2661
17. Myatt, S. S., and Lam, E. W. (2007) The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev. Cancer 7, 847-859
18. Fu, Z., Malureanu, L., Huang, J., Wang, W., Li, H., van Deursen, J. M., Tindall, D. J., and Chen, J. (2008) Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression. Nat Cell Biol. 10, 1076-1082
19. Matsui, Y., Nakayama, Y., Okamoto, M., Fukumoto, Y., and Yamaguchi, N. (2012) Enrichment of cell populations in metaphase, anaphase, and telophase by synchronization using nocodazole and blebbistatin: a novel method suitable for examining dynamic changes in proteins during mitotic progression. Eur. J. Cell Biol. 91, 413-419
20. Yuan, C, Bu, Y., Wang, C, Yi, F., Yang, Z., Huang, X., Cheng, L., Liu, G., Wang, Y., and Song, F. (2012) NFBD1/MDC1 is a protein of oncogenic potential in human cervical cancer. Mol. Cell Biochem. 359, 333-346
21. Rodriguez, M. S., Dargemont, C, and Hay, R. T. (2001) SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276, 12654-12659
22. Desterro, J. M., Rodriguez, M. S., and Hay, R. T. (1998) SUMO-1 modification of IκBα inhibits NF-KB activation. Mol. Cell 2, 233-239
23. Everett, R. D., Lomonte, P., Sternsdorf, T., van Driel, R., and Orr, A. (1999) Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112, 4581-4588
24. Muller, S., Berger, M., Lehembre, F., Seeler, J. S., Haupt, Y., and Dejean, A. (2000) c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275, 13321-13329
25. Holmstrom, S., Van Antwerp, M. E., and Iñiguez-Lluhi, J. A. (2003) Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proc. Natl. Acad. Sci. U.S.A. 100, 15758-15763
26. Ross, S., Best, J. L., Zon, L. I., and Gill, G. (2002) SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell 10, 831-842
27. Yurchenko, V., Xue, Z., and Sadofsky, M. J. (2006) SUMO modification of human XRCC4 regulates its localization and function in DNA double-strand break repair. Mol. Cell. Biol. 26, 1786-1794
28. Endter, C, Kzhyshkowska, J., Stauber, R., and Dobner, T. (2001) SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc. Natl. Acad. Sci. U.S.A. 98, 11312-11317
29. Huang, T. T., Wuerzberger-Davis, S. M., Wu, Z. H, and Miyamoto, S. (2003) Sequential modification of NEMO/IKK7 by SUMO-1 and ubiquitin mediates NF-KB activation by genotoxic stress. Cell 115, 565-576
30. Lin, X., Sun, B., Liang, M., Liang, Y. Y., Gast, A., Hildebrand, J., Brunicardi, F.C., Melchior, F., and Feng, X. H. (2003) Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol. Cell 11, 1389-1396
31. Sobko, A., Ma, H, and Firtel, R. A. (2002) Regulated SUMOylation and ubiquitination of DdMEK1 is required for proper chemotaxis. Dev. Cell 2, 745-756
32. Wood, L. D., Irvin, B. J., Nucifora, G., Luce, K. S., and Hiebert, S. W. (2003) Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor. Proc. Natl. Acad. Sci. U.S.A. 100, 3257-3262
33. Wilkinson, K. A., and Henley, J. M. (2010) Mechanisms, regulation and consequences of protein SUMOylation. Biochem. J. 428, 133-145
34. 2 requires cyclin A/Cdk-dependent relief of autorepression by the FoxM1 N-terminal domain. Mol. Cell. Biol. 28, 3076-3087
35. Buschmann, T., Fuchs, S. Y., Lee, C. G., Pan, Z. Q., and Ronai, Z. (2000) SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell 101, 753-762
36. Wang, C. M., Liu, R., Wang, L., Nascimento, L., Brennan, V. C, and Yang, W. H. (2014) SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells. Int. J. Mol. Sci. 15, 10233-10251
37. Myatt, S. S., Kongsema, M., Man, C. W., Kelly, D. J., Gomes, A. R., Khongkow, P., Karunarathna, U, Zona, S., Langer, J. K., Dunsby, C. W., Coombes, R. C, French, P. M., Brosens, J. J., and Lam, E. W. (2014) SUMOylation inhibits FOXM1 activity and delays mitotic transition. Oncogene 33, 4316-4329
38. Schimmel, J., Eifler, K., Sigurosson, J. O., Cuijpers, S. A., Hendriks, I. A., Verlaan-de Vries, M., Kelstrup, C. D., Francavilla, C, Medema, R. H., Olsen, J. V., and Vertegaal, A. C. (2014) Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein. Mol. Cell 53, 1053-1066
39. Ma, R. Y., Tong, T. H., Cheung, A. M., Tsang, A. C, Leung, W. Y., and Yao, K. M. (2005) Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J. Cell Sci. 118, 795-806
40. Miteva, M., Keusekotten, K., Hofmann, K., Praefcke, G. J., and Dohmen, R. J. (2010) Sumoylation as a signal for polyubiquitylation and proteasomal degradation. Subcell. Biochem. 54, 195-214
41. Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Peres, L., Zhou, J., Zhu, J., Raught, B., and de Thé, H. (2008) Arsenic degrades PML or PML-RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol. 10, 547-555